From: Successful renal transplantation to a recipient with type II cryoglobulinemia: a case report
year | numbers of cases | age | HCV | type | period to recurrence | results |
---|---|---|---|---|---|---|
1989 | 2 | – | mixed | 30 days | graft loss | |
– | mixed | 6 months | graft loss | |||
1994 | 2 | 43 | + | mixed | 10 months | graft dysfunction (last serum Cr is not reported) |
52 | – | mixed | 5 months | graft loss | ||
1996 | 1 | + | TypeI MPGN | 2 years | graft loss | |
2005 | 3 | 60 | – | type 3 | de novo | RIT prevented graft loss but died of infection |
56 | + | type 3 | de novo | RIT prevented graft loss (serum Cr is in 2 mg/dL) | ||
47 | – | type 3 | 6 months | RIT prevented graft dysfunction (serum Cr is at baseline) | ||
2006 | 7 | + in 5 | mixed | de novo | RIT prevented graft loss in 5 | |
- in 2 | 2 died of infection | |||||
2010 | 1 | 50 | – | type 2 | 4 years | graft loss |
2013 | 1 | 46 | – | type 2 | 35 days | GC prevented graft dysfunction (serum Cr is at baseline) |